安全、效力高,資訊透明,才是疫苗廣為接受的條件:Sputnik V疫苗的故事
On 2 February 2021, an interim analysis from the trial was published in The Lancet, indicating 91.6% efficacy without unusual side effects.[4]
https://en.wikipedia.org/wiki/Sputnik_V_COVID-19_vaccine
According to preliminary review by experts, the lyophilized formulation of Gam-COVID-Vac is similar to the smallpox vaccine, circumventing the need for continuous cold chain storage – as required for the Pfizer–BioNTech and Moderna vaccines – and allowing transportation to remote locations with reduced risk of vaccine spoilage.
匈牙利不管歐盟,自己用Sputnik V疫苗
■ Iran announced that its first batch of Covid-19 vaccine, Russia’s Sputnik V, would arrive on Thursday.
沒有留言:
張貼留言